ENHANCEMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL APPS

Recombinant human serum albumin (OsrHSA) has emerged as a substantial innovation in the field of biopharmaceuticals, giving promising breakthroughs throughout several health-related and industrial programs. With its structural similarity to Normally derived human serum albumin, OsrHSA presents a safer, much more trusted alternative for therapeutic